Literature DB >> 10673243

Treatment of aspirin-intolerant asthma with antileukotrienes.

B Dahlén1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673243     DOI: 10.1164/ajrccm.161.supplement_1.ltta-27

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  Aspirin-induced asthma.

Authors:  L T Vaszar; D D Stevenson
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

Review 2.  Recent advances: Respiratory medicine.

Authors:  H A Kerstjens; H J Groen; W van Der Bij
Journal:  BMJ       Date:  2001-12-08

Review 3.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

Review 4.  Montelukast: a review of its therapeutic potential in persistent asthma.

Authors:  B Jarvis; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 5.  Prevention and treatment of reactions to NSAIDs.

Authors:  Ronald A Simon
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 6.  Natural history and clinical features of aspirin-exacerbated respiratory disease.

Authors:  John M Fahrenholz
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 7.  Factors driving the aspirin exacerbated respiratory disease phenotype.

Authors:  John W Steinke; Larry Borish
Journal:  Am J Rhinol Allergy       Date:  2015 Jan-Feb       Impact factor: 2.467

Review 8.  Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

Authors:  John W Steinke; Spencer C Payne; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

Review 9.  Treatment of patients with respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  Ronald A Simon
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

10.  Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.

Authors:  John W Steinke; Julie Negri; Lixia Liu; Spencer C Payne; Larry Borish
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.